HomeSearchExpert Opinion on Drug Safety

Expert Opinion on Drug Safety

Taylor and Francis Ltd. · United Kingdom · Est. 1987

ISSN1474-0338eISSN1744-764X
SJR Q2WOS SCIEScopus / SJR
43
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q2+18
Total43
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
0.785
H-Index
110
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
0.912
Total Works
3,167
Total Citations
78,477
2yr Mean Citedness
2.59
Free JIF alternative
Retractions
3
Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on the safety and tolerability of pharmaceutical agents across various medical conditions. It examines adverse drug reactions, drug interactions, and the long-term safety profiles of both established and novel therapies. The scope includes evaluating safety in specific populations such as the elderly, pregnant women, and children, as well as addressing rare adverse events and the management of immune-related adverse events from oncological treatments.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q2
SJR Rank
Top 50% in field

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1987
Annual Volume~ 230 articles / year
StatusActive (last: 2026)
Total Publications3,167
Publisher OrgTaylor & Francis
Visit Journal Website

Submission Info

Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
Taylor and Francis Ltd.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1474-0338 / 1744-764X
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2
Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Pharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse ReactionsDiabetes Treatment and ManagementRheumatoid Arthritis Research and TherapiesPharmaceutical studies and practicesPharmacological Effects and Toxicity StudiesPregnancy and Medication ImpactSchizophrenia research and treatmentLipoproteins and Cardiovascular HealthPharmaceutical Practices and Patient Outcomes
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref